Use of the cosmid adenoviral vector cloning system for the in vitro construction of recombinant adenoviral vectors.
The large size of the adenoviral genome unfortunately precludes there being many unique, useful restriction sites available for in vitro manipulation. Two methods have been developed for the construction of recombinant adenoviral vectors to date: in vivo homologous recombination or direct ligation in vitro. The efficiency of either the direct ligation method or the homologous recombination method is low because of the large size of the recombinant adenoviral vectors. To circumvent these problems, we have chosen to use the cosmid vector system to facilitate the assembly of recombinant adenoviral vectors. In this paper, we demonstrate for the first time that recombinant adenoviral vectors can be efficiently constructed in vitro by the cosmid vector system. With this method, it is possible to amplify the recombinant adenoviral vector DNA sufficiently to transfect 293 cells. The cosmid adenoviral vector cloning method for in vitro construction of the full-length recombinant adenoviral vectors represented here is simple and efficient and should facilitate the development of recombinant adenoviral vectors for human gene therapy.
Fu
S
S
Section of Medical Oncology, Yale University School of Medicine, New Haven, CT 06520-8023, USA.
Deisseroth
A B
AB
D000256:Adenoviridae / Q000235:genetics*; D003360:Cosmids / Q000235:genetics* / Q000302:isolation & purification; D005818:Genetic Engineering / Q000379:methods*; D005822:Genetic Vectors / Q000235:genetics* / Q000378:metabolism; D008957:Models, Genetic; D016133:Polymerase Chain Reaction; D001616:beta-Galactosidase / Q000378:metabolism
D001616:beta-Galactosidase